1. Home
  2. CTXR vs EBON Comparison

CTXR vs EBON Comparison

Compare CTXR & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • EBON
  • Stock Information
  • Founded
  • CTXR 2007
  • EBON 2010
  • Country
  • CTXR United States
  • EBON China
  • Employees
  • CTXR N/A
  • EBON N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • EBON Semiconductors
  • Sector
  • CTXR Health Care
  • EBON Technology
  • Exchange
  • CTXR Nasdaq
  • EBON Nasdaq
  • Market Cap
  • CTXR 21.6M
  • EBON 25.3M
  • IPO Year
  • CTXR N/A
  • EBON 2020
  • Fundamental
  • Price
  • CTXR $1.67
  • EBON $4.51
  • Analyst Decision
  • CTXR Strong Buy
  • EBON
  • Analyst Count
  • CTXR 3
  • EBON 0
  • Target Price
  • CTXR $53.00
  • EBON N/A
  • AVG Volume (30 Days)
  • CTXR 1.5M
  • EBON 36.2K
  • Earning Date
  • CTXR 08-11-2025
  • EBON 08-22-2025
  • Dividend Yield
  • CTXR N/A
  • EBON N/A
  • EPS Growth
  • CTXR N/A
  • EBON N/A
  • EPS
  • CTXR N/A
  • EBON N/A
  • Revenue
  • CTXR N/A
  • EBON $5,868,771.00
  • Revenue This Year
  • CTXR N/A
  • EBON N/A
  • Revenue Next Year
  • CTXR N/A
  • EBON N/A
  • P/E Ratio
  • CTXR N/A
  • EBON N/A
  • Revenue Growth
  • CTXR N/A
  • EBON 20.88
  • 52 Week Low
  • CTXR $0.65
  • EBON $3.00
  • 52 Week High
  • CTXR $26.25
  • EBON $10.94
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 56.18
  • EBON 54.64
  • Support Level
  • CTXR $1.40
  • EBON $4.64
  • Resistance Level
  • CTXR $1.67
  • EBON $5.10
  • Average True Range (ATR)
  • CTXR 0.18
  • EBON 0.39
  • MACD
  • CTXR -0.03
  • EBON 0.02
  • Stochastic Oscillator
  • CTXR 36.90
  • EBON 58.12

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

Share on Social Networks: